NCT00004112View on ClinicalTrials.gov

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 1, 1999

Primary Completion Date

December 1, 2000

Study Completion Date

March 1, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

CHOP regimen

Cyclophosphamide, vincristine and doxorubicin as a drip into the bloodstream (intravenously) and prednisolone (steroid) as tablets taken with or after food.

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (2)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

68198-3330

University of Nebraska Medical Center, Omaha

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Nebraska

OTHER